Infectious Disease Point Of Care Diagnostics Market: Next-Generation Platforms for Lab Directors, Infection Control Leads, and Diagnostics Executives
Rising demand for rapid bedside pathogen identification, growing emphasis on decentralized and home-based testing, and continuous innovations in lateral flow assays, microfluidics, and near-patient molecular diagnostics are shaping the global Infectious Disease Point Of Care Diagnostics Market, with broader point-of-care infectious disease benchmarks estimated around USD 13.97 billion in 2026...
0 Yorumlar 0 hisse senetleri 2 Views 0 önizleme
social art-inpa https://social.art-inpa.com